Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT00547157 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Head and Neck Cancer
Oncology
Squamous Cell Carcinoma

Interventions

DRUG: Panitumumab
DRUG: Cisplatin

Sponsor

Amgen